FDA Announces Additional Steps to Modernize Clinical Trials

FDA Announces Additional Steps to Modernize Clinical Trials     On June 6, the FDA released E6(R3) Guideline for Good Clinical Practice, a draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernizing the design and conduct of clinical trials, making them more agile without compromising data integrity or participant protections. The updates …

FDA Announces Additional Steps to Modernize Clinical Trials Read More »